CTLA4 and neoplasm: Finally, research has shown that the gut microbiota can alter the tumor microenvironment; for instance, Bacteroides fragilis enhances the efficacy of anti-CTLA-4 therapy by remodeling the tumor microenvironment through immunomodulatory mechanisms [11].